Former Illinois Gov. Jim Edgar announced in a statement Monday that he is battling pancreatic cancer. In the statement, Edgar ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

Pancreatic cancer walk raising awareness ...

In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

Paired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of ...

Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...